Germany has approved a human clinical trial in the search for a Covid-19 vaccine.
Two hundred people will receive the vaccine, developed by the German biotech company BioNTech.
The trial is only the fourth study to be approved worldwide in what has become an urgent race to develop a vaccine.
Berlin correspondent Thomas Sparrow speaks to Susie Ferguson.
